NCT05533697 2026-02-06Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid TumorsModernaTX, Inc.Phase 1/2 Recruiting361 enrolled
NCT06880549 2026-02-05A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid TumorsModernaTX, Inc.Phase 1 Active not recruiting57 enrolled
NCT02628574 2025-08-03Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or NivolumabLeap Therapeutics, Inc.Phase 1 Completed109 enrolled
NCT04084951 2023-04-14Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid TumorsSQZ BiotechnologiesPhase 1 Completed30 enrolled